Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience.

Radiat Oncol J · 2022 · PMC9535412 · PMID 36200308

Europe PMC DOI

hedged sentence

0.1720

closest p · 3.4× alpha

0.1720

boldest claim

The sentences

showed a trendp = 0.172not close (p > 0.1)

Nonetheless, although the data we obtained in our series showed a trend (p = 0.172) in this subgroup of patients, we still lack randomized studies to support this assumption.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.